Argenx
ARGX
#579
Rank
NZ$61.02 B
Marketcap
$998.00
Share price
0.77%
Change (1 day)
18.97%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$7.13 Billion

According to Argenx 's latest financial reports the company has NZ$7.13 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$NZ$4.43 B19.45%
2021-12-31$NZ$3.71 B30.01%
2020-12-31$NZ$2.85 B45.34%
2019-12-31$NZ$1.96 B86.93%
2018-12-31$NZ$1.05 B50.24%
2017-12-31$NZ$0.69 B590.77%
2016-12-31$NZ$0.10 B55.44%
2015-12-31$NZ$65.11 M-31.12%
2014-12-31$NZ$94.53 M87.68%
2013-12-31$NZ$50.36 M88.12%
2012-12-31$NZ$26.77 M-42.32%
2011-12-31$NZ$46.42 M163.13%
2010-12-31$NZ$17.64 M